Anavex Life Sciences Corp (AVXL)

[BAR123]

The only issue about Dr. Missling‘s strategy right now is the fact that he does not let us know what the path is. Why can’t he tell us conclusively how things will play out. For example, if we are waiting for a peer review, article before we release any press release with the data, then say that. Why not tell us what peer review publication we are looking to showcase our data with. Why not tell us some preliminary time frames as to when the peer review article might come out. I know things change and dates slip, but let us know what the goals are here. Same holds true for Rett . What exactly is the path forward with the data. Pier review for that as well or submission to the FDA for an NDA or something different. Just give us some of the strategy without giving away corporate secrets to the competition.